# Image-Guided Thrombin Injection for Post-procedural Hematomas in Various Surgical Settings: A Case Series

**Authors:** Aws Alfahad, Dura Ibrahim, Basil Ibrahim, Rami Alfahad

PMC · DOI: 10.7759/cureus.94879 · Cureus · 2025-10-18

## TL;DR

This case series shows that image-guided thrombin injections can safely and effectively treat post-surgery hematomas when other options are not possible.

## Contribution

The study introduces image-guided thrombin injection as a novel alternative for managing post-procedural hematomas.

## Key findings

- Thrombin injection achieved hemostasis in five patients with post-procedural hematomas.
- No thrombin-related complications occurred, and no surgical intervention was needed.
- The technique was effective across various surgical settings.

## Abstract

Post-procedural hematomas are uncommon but clinically significant complications that can lead to morbidity and mortality. Conventional management often requires surgical re-exploration or embolization, which may be technically unfeasible or high risk in patients with multiple comorbidities. Thrombin injection, although well established for pseudoaneurysm treatment, has been less frequently reported in the management of postsurgical hematomas.

We describe five patients who developed post-procedural hematomas following different interventions: robotic hernia repair, ovarian cystectomy, percutaneous nephrostomy, endoscopy, and percutaneous endoscopic gastrostomy tube insertion. Each patient was treated with image-guided thrombin injection under computed tomography or ultrasound guidance. Hemostasis was successfully achieved in all cases without thrombin-related complications, and patients recovered without the need for surgical or major endovascular intervention.

Image-guided thrombin injection is a safe, effective, and minimally invasive technique for managing selected post-procedural hematomas. This case series highlights its potential as an alternative when conventional surgical or embolization options are not feasible. Further studies are needed to standardize protocols and evaluate long-term outcomes.

## Full-text entities

- **Genes:** F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}
- **Diseases:** pseudoaneurysm (MESH:D017541), Hematomas (MESH:D006406), hernia (MESH:D006547)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12622864/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12622864/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12622864/full.md

---
Source: https://tomesphere.com/paper/PMC12622864